Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.
Comprehensive, easy-to-understand information about this condition
How we create this content →Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Clinical profile data for this condition is not yet available. Phenotype information may still be loading below.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Feb 5, 2026
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning chronic kidney disease
Updated Jan 7, 2026
Emerging healthcare companies are gearing up for IPOs in 2025, with a focus on digital health innovations. Notably, Aptar Digital Health is partnering with AstraZeneca to develop AI algorithms for chronic kidney disease detection, while Wellgistics Health aims to enhance patient outcomes through integrated digital health solutions.